Literature DB >> 20679764

Pandemic influenza vaccine in adult HIV-1-infected patients.

Giovanna Orlando, Elena Pariani, Francesca Mazza, Elisabetta Tanzi, Paola Meraviglia, Erica Gianelli, Barbara Argenteri, Antonella Amendola, Massimo Galli, Giuliano Rizzardini, Alessandro Zanetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20679764     DOI： 10.1097/QAD.0b013e32833cfcb0

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

1.  Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.

Authors:  Chiara Agrati; Cristiana Gioia; Concetta Castilletti; Daniele Lapa; Giulia Berno; Vincenzo Puro; Fabrizio Carletti; Eleonora Cimini; Carla Nisii; Flora Castellino; Federico Martini; Maria R Capobianchi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-08       Impact factor: 2.205

Review 2.  Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Authors:  Anandi N Sheth; Pragna Patel; Philip J Peters
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

3.  Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial.

Authors:  Alessandra Viganò; Vania Giacomet; Elena Pariani; Elisa Giani; Valeria Manfredini; Giorgio Bedogni; Paola Erba; Antonella Amendola; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

4.  Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults.

Authors:  Shuji Hatakeyama; Kiyoko Iwatsuki-Horimoto; Koh Okamoto; Yoko Nukui; Nahoko Yata; Akira Fujita; Shigeki Inaba; Hiroshi Yotsuyanagi; Yoshihiro Kawaoka
Journal:  Vaccine       Date:  2011-10-05       Impact factor: 3.641

5.  Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand.

Authors:  Nuntisa Chotirosniramit; Patcharaphan Sugandhavesa; Linda Aurpibul; Sunida Thetket; Natthapol Kosashunhanan; Taweewat Supindham; Panuwat Wongkulab; Quanhathai Kaewpoowat; Kanokporn Chaiklang; Oranitcha Kaewthip; Piyathida Sroysuwan; Antika Wongthanee; Hatairat Lerdsamran; Pilaipan Puthavathana; Khuanchai Suparatpinyo
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

6.  High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine.

Authors:  Karen K Yam; Erica Gipson; Marina Klein; Sharon Walmsley; David Haase; Scott Halperin; David Scheifele; Brian J Ward; Curtis Cooper
Journal:  J Clin Immunol       Date:  2014-05-14       Impact factor: 8.317

7.  Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohort.

Authors:  B Steffens; T Kümmerle; S Koch; A Birtel; C Schwarze-Zander; J Emmelkamp; W V Kern; C Hertenstein; C Wyen; C Lehmann; O A Cornely; J Rockstroh; Gerd Fätkenheuer
Journal:  Eur J Med Res       Date:  2011-07-25       Impact factor: 2.175

8.  Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.

Authors:  Darius Soonawala; Guus F Rimmelzwaan; Luc B S Gelinck; Leo G Visser; Frank P Kroon
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

Review 9.  Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.

Authors:  Charles R Beck; Bruce C McKenzie; Ahmed B Hashim; Rebecca C Harris; Arina Zanuzdana; Gabriel Agboado; Elizabeth Orton; Laura Béchard-Evans; Gemma Morgan; Charlotte Stevenson; Rachel Weston; Mitsuru Mukaigawara; Joanne Enstone; Glenda Augustine; Mobasher Butt; Sophie Kim; Richard Puleston; Girija Dabke; Robert Howard; Julie O'Boyle; Mary O'Brien; Lauren Ahyow; Helene Denness; Siobhan Farmer; Jose Figureroa; Paul Fisher; Felix Greaves; Munib Haroon; Sophie Haroon; Caroline Hird; Rachel Isba; David A Ishola; Marko Kerac; Vivienne Parish; Jonathan Roberts; Julia Rosser; Sarah Theaker; Dean Wallace; Neil Wigglesworth; Liz Lingard; Yana Vinogradova; Hiroshi Horiuchi; Javier Peñalver; Jonathan S Nguyen-Van-Tam
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

10.  Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.

Authors:  Heimo Lagler; Katharina Grabmeier-Pfistershammer; Veronique Touzeau-Römer; Selma Tobudic; Michael Ramharter; Judith Wenisch; Guido Andrés Gualdoni; Monika Redlberger-Fritz; Theresia Popow-Kraupp; Armin Rieger; Heinz Burgmann
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.